Catalytic Asymmetric [4+2]‐Cycloadditions Using Tropolones: Developments, Scope, Transformations, and Bioactivity

An organocatalyzed asymmetric [4+2]‐cycloaddition between tropolones and electron‐deficient dienophiles is presented. Complex and biologically interesting dihydrohomobarrelenone scaffolds are formed through a Diels–Alder reaction utilizing bifunctional Brønsted‐base catalysis, affording the correspo...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Angewandte Chemie International Edition 2018-10, Vol.57 (40), p.13216-13220
Hauptverfasser: Hammer, Niels, Erickson, Jeremy D., Lauridsen, Vibeke H., Jakobsen, Joakim B., Hansen, Bente K., Jacobsen, Kristian M., Poulsen, Thomas B., Jørgensen, Karl Anker
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:An organocatalyzed asymmetric [4+2]‐cycloaddition between tropolones and electron‐deficient dienophiles is presented. Complex and biologically interesting dihydrohomobarrelenone scaffolds are formed through a Diels–Alder reaction utilizing bifunctional Brønsted‐base catalysis, affording the corresponding bridged bicyclic cycloadducts in up to quantitative yields with good enantio‐ (up to 92 % ee) and diastereoselectivity (up to >20:1 d.r.). The synthetic value of the obtained products is explored by downstream transformations, including photoisomerizations, and their biological relevancy by in vivo testing in MCF‐7 cancer cells. Complex and biologically interesting dihydrohomobarrelenone scaffolds were synthesized through a Diels–Alder reaction between tropolones and electron‐deficient dienophiles, utilizing bifunctional Brønsted‐base catalysis. The synthetic value of the obtained products was explored by downstream transformations and biological relevancy by in vivo testing in MCF‐7 cancer cells.
ISSN:1433-7851
1521-3773
DOI:10.1002/anie.201808221